Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions

Douglas G. Adler, MD

Question 18: What Is The Role Of Metal Biliary Stents In Patients With Unresectable Pancreatic Cancer And Jaundice? (continued)

Sergey V. Kantsevoy, MD, PhD

More than 33,000 people are diagnosed with pancreatic cancer in the United States every year.1 Only 15% to 20% of the patients who are diagnosed with pancreatic cancer will have resectable disease at the time of initial presentation.2 The median survival of these patients varies from 3 to 6 months (for patients with remote metastases) to 7 to 12 months (those with locally advanced, unresectable pancreatic cancer).3 Patients with the cancer located in the pancreatic head usually present with obstructive jaundice and pruritis, and palliation of these symptoms and its consequences significantly…
The GI Bookshelf Related Content